{"version":"1.0","type":"link","title":"Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649.","author_name":"Janjigian YY 외","author_url":"https://prs-insight.online/author/Janjigian%20YY","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/121950","thumbnail_width":1200,"thumbnail_height":630}